The effect of fluvastatin on plasma adiponectin levels in dyslipidaemia

Clinical Endocrinology

Volumn 64, Issue 5, 2006, Pages 567-572

  Sonmez, Alper ^a   Dogru, Teoman ^a   Tasci, Ilker ^a   Yilmaz, M Ilker ^a   Pinar, Murat ^a   Naharci, Ilkin ^a   Bingol, Necati ^b   Kilic, Selim ^a   Demirtas, Ayla ^a   Bingol, Sezin ^c   Ozgurtas, Taner ^a   Erikci, Selahattin ^a  

^a GULHANE SCHOOL OF MEDICINE   (Turkey)

^b Bayindir Medical Center   (Turkey)

^c ANKARA NUMUNE HOSPITAL   (Turkey)

Author keywords

[No Author keywords available]

Indexed keywords

ADIPONECTIN; CHOLESTEROL; FLUINDOSTATIN; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; IMMUNOREACTIVE INSULIN; LOW DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; ARTICLE; BEHAVIOR MODIFICATION; BLOOD PRESSURE; BODY MASS; CHOLESTEROL BLOOD LEVEL; CLINICAL ARTICLE; DIAGNOSTIC ACCURACY; DRUG EFFECT; DYSLIPIDEMIA; FEMALE; GLUCOSE BLOOD LEVEL; HUMAN; INSULIN RESISTANCE; INSULIN SENSITIVITY; LIFESTYLE; LIPID BLOOD LEVEL; MALE; PRIORITY JOURNAL; WAIST CIRCUMFERENCE;

ADIPONECTIN; ADULT; ANTICHOLESTEREMIC AGENTS; BLOOD GLUCOSE; CASE-CONTROL STUDIES; CHOLESTEROL; CHOLESTEROL, LDL; DYSLIPIDEMIAS; FATTY ACIDS, MONOUNSATURATED; FEMALE; HOMEOSTASIS; HUMANS; INDOLES; INSULIN; MALE; MIDDLE AGED; STATISTICS, NONPARAMETRIC; TRIGLYCERIDES;

EID: 33645962501     PISSN: 03000664     EISSN: 13652265     Source Type: Journal    
DOI: 10.1111/j.1365-2265.2006.02510.x     Document Type: Article

References (38)

1. Despres J.P. Lamarche B. Mauriege P. Cantin B. Dagenais G.R. Moorjani S. Lupien P.J. 1996 Hyperinsulinaemia as an independent risk factor for ischemic heart disease. New England Journal of Medicine 334 952 957.
2. Yip J. Facchini F.S. Reaven G.M. 1998 Resistance to insulin-mediated glucose disposal as a predictor of cardiovascular disease. Journal of Clinical Endocrinology and Metabolism 83 2773 2776.
3. Sowers J.R. Frohlich E.D. 2004 Insulin and insulin resistance: impact on blood pressure and cardiovascular disease. Medical Clinics of North America 88 63 82.
4. Maeda K. Okubo K. Shimomura I. Funahashi T. Matsuzawa Y. Matsubara K. 1996 cDNA cloning and expression of a novel adipose specific collagen-like factor, apM1 (Adipose Most Abundant Gene transcript 1). Biochemical and Biophysical Research Communications 221 286 289.
5. Kumada M. Kihara S. Sumitsuji S. Kawamato T. Matsumoto S. Ouchi N. Arita Y. Okamoto Y. Shimomura I. Hiraoka H. Nakamura T. Funahashi T. Matsuzawa Y. the Osaka CAD Study Group 2003 Coronary artery disease. Association of hypoadiponectinemia with coronary artery disease in men. Arteriosclerosis, Thrombosis and Vascular Biology 23 85 89.
6. Weyer C. Funahashi T. Tanaka S. Hotta K. Matsuzawa Y. Pratley R.E. Tataranni P.A. 2001 Hypoadiponectinaemia in obesity and type-2 diabetes: close association with insulin resistance and hyperinsulinaemia. Journal of Clinical Endocrinology and Metabolism 86 193 1935.
7. Matsubara M. Maruoka S. Katayose S. 2002 Decreased plasma adiponectin concentrations in women with dyslipidaemia. Journal of Clinical Endocrinology and Metabolism 87 2764 2769.
8. Miyazaki T. Shimada K. Mokuno H. Daida H. 2003 Adipocyte derived plasma protein, adiponectin, is associated with smoking status in patients with coronary artery disease. Heart 89 663.
9. Pedersen T.R. Kjekshus J. Berg K. Haghfelt T. Faergeman O. Faergeman G. Pyorala K. Miettinen T. Wilhelmsen L. Olsson A.G. Wedel H. Scandinavian Simvastatin Survival Study Group 2004 Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S). Atherosclerosis Supplement 5 81 87.
10. Shepherd J. Cobbe S.M. Ford I. Isles C.G. Lorimer A.R. MacFarlane P.W. McKillop J.H. Packard C.J. 1995 Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia. West of Scotland Coronary Prevention Study Group. New England Journal of Medicine 333 1301 1307.
11. Liao J.K. 2005 Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition beyond low-density lipoprotein cholesterol. American Journal of Cardiology 96 24 33.
12. Sebestjen M. Zegura B. Keber I. 2002 Both cerivastatin and fenofibrate improve arterial vasoreactivity in patients with combined hyperlipidaemia. Journal of Internal Medicine 251 7785.
13. Yamakawa T. Tanaka S. Kamei J. Kadonosono K. Okuda K. 2003 Pitavastatin inhibits vascular smooth muscle cell proliferation by inactivating extracellular signal-regulated kinases 1/2. Journal of Atherosclerosis and Thrombosis 10 37 42.
14. Yilmaz M.I. Baykal Y. Kilic M. Sonmez A. Bulucu F. Aydin A. Sayal A. Kocar I.H. 2004 Effects of statins on oxidative stress. Biological Trace Element Research 98 119 127.
15. Steffens S. Mach F. 2004 Anti-inflammatory properties of statins. Seminars in Vascular Medicine 4 417 422.
16. Farrer M. Winocour P.H. Evans K. Neil H.A. Laker M.F. Kesteven P. Alberti K.G. 1994 Simvastatin in non-insulin-dependent diabetes mellitus: effect on serum lipids, lipoproteins and haemostatic measures. Diabetes Research and Clinical Practice 23 111 119.
17. Koh K.K. Quon M.J. Han S.H. Chung W.J. Ahn J.Y. Seo Y.H. Choi I.S. Shin E.K. 2005 Additive beneficial effects of fenofibrate combined with atorvastatin in the treatment of combined hyperlipidemia. Journal of the American College of Cardiology 45 1649 1653.
18. Gannage-Yared M.H. Azar R.R. Amm-Azar M. Khalife S. Germanos-Haddad M. Neemtallah R. Halaby G. 2005 Pravastatin does not affect insulin sensitivity and adipocytokines levels in healthy nondiabetic patients. Metabolism 54 947 951.
19. Ohrvall M. Lithell H. Johansson J. Vessby B. 1995 A comparison between the effects of gemfibrozil and simvastatin on insulin sensitivity in patients with non-insulin-dependent diabetes mellitus and hyperlipoproteinemia. Metabolism 44 212 217.
20. Jula A. Marniemi J. Huupponen R. Virtanen A. Rastas M. Ronnemaa T. 2002 Effects of diet and simvastatin on serum lipids, insulin, and antioxidants in hypercholesterolemic men: a randomized controlled trial. Journal of the American Medical Association 287 598 605.
21. Ohmura C. Watada H. Hirose T. Tanaka Y. Kawamori R. 2005 Acute onset and worsening of diabetes concurrent with administration of statins. Endocrine Journal 52 369 372.
22. Cingozbay B.Y. Top C. Terekeci H. Keskin O. Onde M.E. 2002 Effects of fluvastatin treatment on insulin sensitivity in patients with hyperlipidaemia. Journal of International Medical Research 30 21 25.
23. Sonmez A. Baykal Y. Kilic M. Yilmaz M.I. Saglam K. Bulucu F. Kocar I.H. 2003 Fluvastatin improves insulin resistance in nondiabetic dyslipidaemic patients. Endocrine 22 151 154.
24. Paolisso G. Barbagallo M. Petrella G. Ragno E. Barbieri M. Giordano M. Varricchio M. 2000 Effects of simvastatin and atorvastatin administration on insulin resistance and respiratory quotient in aged dyslipidaemic non-insulin dependent diabetic patients. Atherosclerosis 150 121 127.
25. Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults 2001 Journal of the American Medical Association 285 2486 2497.
26. William T. Friedewald, Robert I. Levy & Fredrickson D.S. 1972 Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clinical Chemistry 18 499 502.
27. Matthews D.R. Hosker J.P. Rudenski A.S. Naylor B.A. Treacher D.F. Turner R.C. 1985 Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man. Diabetologia 28 412 419.
28. Trujillo M.E. Scherer P.E. 2005 Adiponectin - journey from an adipocyte secretory protein to biomarker of the metabolic syndrome. Journal of Internal Medicine 257 167 175.
29. Yamauchi T. Kamon J. Waki H. Murakami K. Motojima K. Komeda K. Ide T. Kubota N. Terauchi Y. Tobe K. Miki H. Tsuchida A. Akanuma Y. Nagai R. Kimura S. Kadowaki T. 2002 Disruption of adiponectin causes insulin resistance and neointimal formation. Journal of Biological Chemistry 277 25863 25866.
30. Arita Y. Kihara S. Ouchi N. Maeda K. Kuriyama H. Okamoto Y. Kumada M. Hotta K. Nishida M. Takahashi M. Nakamura T. Shimomura I. Muraguchi M. Ohmoto Y. Funahashi T. Matsuzawa Y. 2002 Adipocyte-derived plasma protein adiponectin acts as a platelet-derived growth factor-BB-binding protein and regulates growth factor-induced common postreceptor signal in vascular smooth muscle cell. Circulation 105 2893 2898.
31. Pischon T. Girman C.J. Hotamisligil G.S. Rifai N. Hu F.B. Rim E.B. 2004 Plasma adiponectin levels and risk of myocardial infarction in men. Journal of the American Medical Association 291 1730 1737.
32. Koh K.K. Quon M.J. Han S.H. Ahn J.Y. Jin D.K. Kim H.S. Kim D.S. Shin E.K. 2005 Vascular and metabolic effects of combined therapy with ramipril and simvastatin in patients with type 2 diabetes. Hypertension 45 1088 1093.
33. Pritchett A.M. Foreyt J.P. Mann D.L. 2005 Treatment of the metabolic syndrome: the impact of lifestyle modification. Current Atherosclerosis Reports 7 95 102.
34. 2+ channels in rat islet beta-cells. British Journal of Pharmacology 126 1205 1213.
35. Chamberlain L.H. 2001 Inhibition of isoprenoid biosynthesis causes insulin resistance in 3T3-L1 adipocytes. FEBS Letters 507 357 361.
36. Monzillo L.U. Hamdy O. Horton E.S. Ledbury S. Mullooly C. Jarema C. Porter S. Ovalle K. Moussa A. Mantzoros C.S. 2003 Effect of lifestyle modification on adipokine levels in obese subjects with insulin resistance. Obesity Research 11 1048 1054.
37. Esposito K. Pontillo A. Di Palo C. Giugliano G. Masella M. Marfella R. Giugliano D. 2003 Effect of weight loss and lifestyle changes on vascular inflammatory markers in obese women: a randomized trial. Journal of the American Medical Association 289 1799 1804.
38. Koh K.K. Quon M.J. Han S.H. Chung W.J. Ahn J.Y. Seo Y.H. Kang M.H. Ahn T.H. Choi I.S. Shin E.K. 2004 Additive beneficial effects of losartan combined with simvastatin in the treatment of hypercholesterolemic, hypertensive patients. Circulation 110 3687 3692.